Key result
Upfront femoral snaring for TLE demonstrates similar safety and efficacy to conventional approaches.
Why the study?
Transvenous lead extractions have become increasingly complex, necessitating novel techniques to improve safety and effectiveness for long-dwelling leads.
Does an upfront femoral snaring technique improve procedural outcomes and safety compared to a conventional approach in patients undergoing transvenous lead extraction for long-dwelling leads?
Cohort (n=59)
Does an upfront femoral snaring technique improve procedural outcomes and safety compared to a conventional approach in patients undergoing transvenous lead extraction for long-dwelling leads?
A novel upfront femoral snaring technique for transvenous lead extraction of long-dwelling leads appears safe and effective compared to conventional approaches, despite being utilized in an older and sicker patient cohort.
Supports upfront femoral snaring in complex TLE; hypothesis-generating and requires randomized trials before practice change.
BACKGROUND: Increasingly, transvenous lead extractions (TLEs) have become more complex. OBJECTIVE: This study aimed to describe a novel technique for femoral snaring using commercially available equipment and study the application of this technique for a tandem approach in TLE cases with long-dwelling leads compared with conventional TLE. METHODS: We include 59 patients with long-dwelling transvenous leads who underwent powered sheath TLE with either upfront femoral snaring (n = 25) or conventional approach (n = 34). Our femoral snaring technique uses a grasping device within telescoped sheaths creating a rail for powered sheath advancement and lead dissection. Clinical and procedural data were obtained via manual electronic medical record review. RESULTS: Among our study cohort, 74.6% were men, the mean age was 66.1 ± 16.8 years, 57.6% were pacemaker dependent, 72.9% underwent TLE for infection, and the mean dwell time was 15.0 ± 4.7 years. The mean number of cardiac implantable electronic device leads and implantable cardioverter-defibrillator coils was 2.3 ± 1.0 and 1.8 ± 0.8, respectively. Compared with controls, intervention patients were older (72.5 ± 11.4 years vs 61.4 ± 18.6 years; P < .01) and more likely to have ischemic cardiomyopathy (52.0% vs 29.4%; P = .04), lower left ventricular ejection fraction (41.8% ± 15.7% vs 49.8% ± 11.8%; P = .02), hypertension (84.0% vs 61.8%; P = .03), diabetes (76.0% vs 14.7%; P < .01), and right-sided leads (28.0% vs 2.9%; P < .01). No significant differences were observed in procedure or fluoroscopy times with a signal of lower complication rate among the intervention group. The only procedural mortality occurred in the control group. CONCLUSION: We describe a novel upfront tandem TLE technique using commercially available items applied to long-dwelling leads. This technique was safe and effective compared with contemporary controls.
No takes yet. Share an insight, caveat, or question.
Howard et al. (2025) conducted a cohort in Long-dwelling transvenous leads requiring extraction (n=59). Upfront femoral snaring for tandem approach vs. Conventional transvenous lead extraction approach was evaluated on Procedure times, fluoroscopy times, and complication rates. Upfront femoral snaring for transvenous lead extraction was safe and effective compared to conventional TLE, with 0 procedural deaths in the snaring group versus 1 in the control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: